DUSP22 and neoplasm: In the Long-Read POG cohort, 63.11% of tumor samples with ASE in DUSP22 showed allele-specific promoter methylation in trans and 81.15% showed allele-specific gene body methylation in cis with the major expressed allele (Figure S9).